Skip to main content
SpringerLink
Log in

Mitochondrial ribosome and Ménière’s disease: a pilot study

  • Short Communication
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Ménière’s disease patients experience vestibular disability. When most of medical treatments fail, a chemical labyrinthectomy using aminoglycosides is indicated. However, this process frequently causes hearing damage. Aminoglycosides, interacting with mitochondrial rRNAs, alter mitochondrial protein synthesis and the oxidative phosphorylation system, which provide most of the energy in sensory hair cells. For this reason, we hypothesized that genetic variation in mitochondrial rRNA genes and in two nuclear genes coding for proteins that also modify the susceptibility to aminoglycosides might affect the risk of hearing loss in Ménière’s disease patients suffering chemical labyrinthectomy. However, there were no differences in mitochondrial rRNA, TFB1M or MRPS12 genetic variation between those patients that experienced or did not experience hearing loss. This is only a pilot study and larger studies are required to use this therapeutic approach in a rational way and decrease the risk of hearing damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Silverstein H, Wazen J, Van Ess MJ, Daugherty J, Alameda YA (2010) Intratympanic gentamicin treatment of patients with Meniere’s disease with normal hearing. Otolaryngol Head Neck Surg 142(4):570–575

    Article  PubMed  Google Scholar 

  2. Perez-Delgado L, Fraile-Rodrigo J, Astier-Peña P (2011) Intratympanic gentamicin in Ménière’s disease: our experience. J Laryngol Otol 125:363–369

    Article  Google Scholar 

  3. Prezant TR, Agapian JV, Bohlman MC, Bu X, Oztas S, Qiu WQ, Arnos KS, Cortopassi GA, Jaber L, Rotter JI et al (1993) Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 4(3):289–294

    Article  PubMed  CAS  Google Scholar 

  4. Zhao H, Li R, Wang Q, Yan Q, Deng JH, Han D, Bai Y, Young WY, Guan MX (2004) Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family. Am J Hum Genet 74(1):139–152

    Article  PubMed  CAS  Google Scholar 

  5. Vandebona H, Mitchell P, Manwaring N, Griffiths K, Gopinath B, Wang JJ, Sue CM (2009) Prevalence of mitochondrial 1555A → G mutation in adults of European descent. N Engl J Med 360(6):642–644

    Article  PubMed  CAS  Google Scholar 

  6. Ruiz-Pesini E, Wallace DC (2006) Evidence for adaptive selection acting on the tRNA and rRNA genes of human mitochondrial DNA. Hum Mutat 27(11):1072–1081

    Article  PubMed  CAS  Google Scholar 

  7. Vila-Sanjurjo A, Lu Y, Aragonez JL, Starkweather RE, Sasikumar M, O’Connor M (2007) Modulation of 16S rRNA function by ribosomal protein S12. Biochim Biophys Acta 1769(7–8):462–471. doi:10.1016/j.bbaexp.2007.04.004

    PubMed  CAS  Google Scholar 

  8. Cotney J, Wang Z, Shadel GS (2007) Relative abundance of the human mitochondrial transcription system and distinct roles for h-mtTFB1 and h-mtTFB2 in mitochondrial biogenesis and gene expression. Nucleic Acids Res 35(12):4042–4054

    Article  PubMed  CAS  Google Scholar 

  9. Equilibrium TCoHa (1995) Committee on Hearing and Equilibrium guidelines for the evaluation of results of treatment of conductive hearing loss. American Academy of Otolaryngology-Head and Neck Surgery Foundation, Inc. Otolaryngol Head Neck Surg 113:186–187

    Article  Google Scholar 

  10. Gomez-Duran A, Pacheu-Grau D, Lopez-Gallardo E, Diez-Sanchez C, Montoya J, Lopez-Perez MJ, Ruiz-Pesini E (2009) Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum Mol Genet 19(17):3343–3353

    Article  Google Scholar 

  11. Ruiz-Pesini E, Lott MT, Procaccio V, Poole JC, Brandon MC, Mishmar D, Yi C, Kreuziger J, Baldi P, Wallace DC (2007) An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res 35(Database issue):D823–D828

    Article  PubMed  CAS  Google Scholar 

  12. Alonso-Montes C, Castro MG, Reguero JR, Perrot A, Ozcelik C, Geier C, Posch MG, Moris C, Alvarez V, Ruiz-Ortega M, Coto E (2008) Mitochondrial transcription factors TFA, TFB1 and TFB2: a search for DNA variants/haplotypes and the risk of cardiac hypertrophy. Dis Markers 25(3):131–139

    PubMed  CAS  Google Scholar 

  13. Manwaring N, Jones MM, Wang JJ, Rochtchina E, Howard C, Newall P, Mitchell P, Sue CM (2007) Mitochondrial DNA haplogroups and age-related hearing loss. Arch Otolaryngol Head Neck Surg 133(9):929–933

    Article  PubMed  Google Scholar 

  14. Scheunemann AE, Graham WD, Vendeix FA, Agris PF (2010) Binding of aminoglycoside antibiotics to helix 69 of 23S rRNA. Nucleic Acids Res 38(9):3094–3105

    Article  PubMed  CAS  Google Scholar 

  15. Shah ZH, Toompuu M, Hakkinen T, Rovio AT, van Ravenswaay C, De Leenheer EM, Smith RJ, Cremers FP, Cremers CW, Jacobs HT (2001) Novel coding-region polymorphisms in mitochondrial seryl-tRNA synthetase (SARSM) and mitoribosomal protein S12 (RPMS12) genes in DFNA4 autosomal dominant deafness families. Hum Mutat 17(5):433–434. doi:10.1002/humu.1122

    Article  PubMed  CAS  Google Scholar 

  16. Pacheu-Grau D, Gomez-Duran A, Lopez-Perez MJ, Montoya J, Ruiz-Pesini E (2010) Mitochondrial pharmacogenomics: barcode for antibiotic therapy. Drug Discov Today 15(1–2):33–39

    Article  PubMed  CAS  Google Scholar 

  17. Pacheu-Grau D, Gomez-Duran A, Montoya J, Ruiz-Pesini E (2010) Influence of mtDNA genetic variation on antibiotic therapy. Pharmacogenomics 11(9):1185–1187

    Article  PubMed  CAS  Google Scholar 

  18. Chen JM, Williamson PA, Hutchin T, Nedzelski JM, Cortopassi GA (1996) Topical gentamicin-induced hearing loss: a mitochondrial ribosomal RNA study of genetic susceptibility. Am J Otol 17(6):850–852

    PubMed  CAS  Google Scholar 

  19. Walsted A (2001) Unpredictable hearing loss after intratympanic gentamicin treatment for vertigo. A new theory. Acta Otolaryngol 121(1):42–44

    Article  PubMed  CAS  Google Scholar 

  20. Guan MX, Yan Q, Li X, Bykhovskaya Y, Gallo-Teran J, Hajek P, Umeda N, Zhao H, Garrido G, Mengesha E, Suzuki T, del Castillo I, Peters JL, Li R, Qian Y, Wang X, Ballana E, Shohat M, Lu J, Estivill X, Watanabe K, Fischel-Ghodsian N (2006) Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations. Am J Hum Genet 79(2):291–302. doi:10.1086/506389

    Article  PubMed  CAS  Google Scholar 

  21. Campos Y, Garcia A, Lopez A, Jimenez S, Rubio JC, Del Hoyo P, Bustos F, Martin MA, Cabello A, Ricoy JR, Arenas J (2002) Cosegregation of the mitochondrial DNA A1555G and G4309A mutations results in deafness and mitochondrial myopathy. Muscle Nerve 25(2):185–188. doi:10.1002/mus.10012

    Article  PubMed  CAS  Google Scholar 

  22. Wang X, Lu J, Zhu Y, Yang A, Yang L, Li R, Chen B, Qian Y, Tang X, Wang J, Zhang X, Guan MX (2008) Mitochondrial tRNAThr G15927A mutation may modulate the phenotypic manifestation of ototoxic 12S rRNA A1555G mutation in four Chinese families. Pharmacogenet Genomics 18(12):1059–1070. doi:10.1097/FPC.0b013e3283131661

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We would like to thank Ana Anguas and MariLuz Pérez from Servicio de Otorrinolaringología, Hospital Miguel Servet, for their help in the sample collection. This project was supported by grants from the Instituto de Salud Carlos III (FIS-PI10-00662 and FIS-PI11-01301) and Diputación General de Aragón (Grupos consolidados B33). The CIBERER is an initiative of the ISCIII.

Conflict of interest

The authors report no declarations of interest.

Author information

Authors and Affiliations

  1. Departamento de Bioquímica, Biología Molecular y Celular, Centro de Investigaciones Biomédicas En Red de Enfermedades Raras (CIBERER), Universidad de Zaragoza, C/Miguel Servet, 177, 50013, Zaragoza, Spain

    David Pacheu-Grau, Julio Montoya & Eduardo Ruiz-Pesini

  2. Fundación ARAID, Universidad de Zaragoza, Zaragoza, Spain

    Eduardo Ruiz-Pesini

  3. Servicio de Otorrinolaringología, Hospital Miguel Servet, Zaragoza, Spain

    Laura Pérez-Delgado, Covadonga Gómez-Díaz & Jesus Fraile-Rodrigo

Authors
  1. David Pacheu-Grau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Pérez-Delgado
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Covadonga Gómez-Díaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jesus Fraile-Rodrigo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Julio Montoya
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Eduardo Ruiz-Pesini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eduardo Ruiz-Pesini.

Additional information

D. Pacheu-Grau and L. Pérez-Delgado have equally contributed to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pacheu-Grau, D., Pérez-Delgado, L., Gómez-Díaz, C. et al. Mitochondrial ribosome and Ménière’s disease: a pilot study. Eur Arch Otorhinolaryngol 269, 2003–2008 (2012). https://doi.org/10.1007/s00405-012-2066-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-012-2066-8

Keywords

Search

Navigation